| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.66 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.65 | 0.002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |